Deciphera Pharmaceuticals (Series B and C)
Funding Details
- Awarder
- Inbox
- Date Award
- September 21, 2015
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $217,000,000
Company Info
- Company Description
- Deciphera Pharmaceuticals focuses on improving kinase inhibitor treatments.
- Market
- Cancer treatment
- Location
- Waltham, MA, USA
- Coinvestors
- Redmile Group, Sphera Global Healthcare, Viking Global Investors